PolyPeptide Group AG (0AAJ.L) LSE

26.00

+0(+0.00%)

Updated at September 08 09:56AM

Currency In CHF

PolyPeptide Group AG

Address

Dammstrasse 19

Baar, 6300

Switzerland

Phone

41 41 723 20 34

Sector

Healthcare

Industry

Biotechnology

Employees

1362

First IPO Date

November 12, 2021

Key Executives

NameTitlePayYear Born
Mr. Juan Jose GonzalezChief Executive Officer1.39M1972
Ms. Christina Del VecchioChief Legal Officer & Corporate Secretary01978
Ms. Monika CasanovaChief Human Resources Officer01979
Mr. Jens FrickeDirector of Global Operations01965
Trishul Shah MSInterim Director Global Sales & Marketing0N/A
Mr. Michael StaheliHead of Investor Relations & Corporate Communications01965
Mr. Marc AugustinChief Financial Officer01972
Rene VestergaardDirector of Corporate Finance0N/A
Mr. Olivier Ludemann-HombourgerDirector of Global Innovation & Technology01972
Andreas LieseCorporate Compliance Manager0N/A

Description

PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.